These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35382506)

  • 1. Reasons for attending support groups and organizational preferences: A replication study using the North American Scleroderma Support Group Survey.
    Pépin M; Kwakkenbos L; Carrier ME; Peláez S; El-Baalbaki G; Malcarne VL; Thombs BD;
    J Scleroderma Relat Disord; 2019 Oct; 4(3):173-186. PubMed ID: 35382506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for attending support groups and organizational preferences: the European scleroderma support group members survey.
    Gumuchian ST; Delisle VC; Kwakkenbos L; Pépin M; Carrier ME; Malcarne VL; Peláez S; El-Baalbaki G; Thombs BD;
    Disabil Rehabil; 2019 Apr; 41(8):974-982. PubMed ID: 29254393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for Not Participating in Scleroderma Patient Support Groups: A Cross-Sectional Study.
    Gumuchian ST; Delisle VC; Peláez S; Malcarne VL; El-Baalbaki G; Kwakkenbos L; Jewett LR; Carrier ME; Pépin M; Thombs BD;
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):275-283. PubMed ID: 28217869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for not participating in scleroderma patient support groups: a comparison of results from the North American and European scleroderma support group surveys.
    Kwakkenbos L; Carboni-Jiménez A; Carrier ME; Pépin M; Peláez S; Malcarne VL; El-Baalbaki G; Thombs BD;
    Disabil Rehabil; 2021 May; 43(9):1279-1286. PubMed ID: 31522575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Support and information needs of people with systemic sclerosis by time since diagnosis: A cross-sectional study.
    Provencher S; Henry RS; Bacalao C; Carrier ME; Kwakkenbos L; Thombs BD;
    J Scleroderma Relat Disord; 2023 Oct; 8(3):247-252. PubMed ID: 37744044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Training and support needs of scleroderma support group facilitators: the North American Scleroderma Support Group Facilitators Survey.
    Delisle VC; Gumuchian ST; El-Baalbaki G; Körner A; Malcarne VL; Peláez S; Carrier ME; Pépin M; Thombs BD;
    Disabil Rehabil; 2019 Oct; 41(20):2477-2482. PubMed ID: 29696997
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of the nominal group technique to identify stakeholder priorities and inform survey development: an example with informal caregivers of people with scleroderma.
    Rice DB; Cañedo-Ayala M; Turner KA; Gumuchian ST; Malcarne VL; Hagedoorn M; Thombs BD;
    BMJ Open; 2018 Mar; 8(3):e019726. PubMed ID: 29500214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Instagram Use Across Cultures: A Confirmatory Factor Analysis.
    Schaffer DR; Debb SM
    Cyberpsychol Behav Soc Netw; 2020 Feb; 23(2):100-106. PubMed ID: 31913711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Item Functioning on the Cochin Hand Function Scale Among People With Systemic Sclerosis by Language, Sex, and Disease Subtype: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study.
    Xu M; Harel D; Carrier ME; Kwakkenbos L; Bartlett SJ; Gottesman K; Guillot G; Hummers L; Malcarne VL; Richard M; Thombs BD;
    Arthritis Care Res (Hoboken); 2023 Jul; ():. PubMed ID: 37489073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis.
    Jewett LR; Hudson M; Haythornthwaite JA; Heinberg L; Wigley FM; Baron M; Thombs BD;
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1779-86. PubMed ID: 20665750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for non-participation in scleroderma support groups.
    Delisle VC; Gumuchian ST; Pelaez S; Malcarne VL; El-Baalbaki G; Körner A; Hudson M; Baron M; Thombs BD;
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):56-62. PubMed ID: 26950221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of the Body Concealment Scale for Scleroderma.
    Jewett LR; Malcarne VL; Kwakkenbos L; Harcourt D; Rumsey N; Körner A; Steele RJ; Hudson M; Baron M; Haythornthwaite JA; Heinberg L; Wigley FM; Thombs BD;
    Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1158-65. PubMed ID: 26663624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and preliminary validation of the Scleroderma Support Group Leader Self-efficacy Scale.
    Pal NE; Gumuchian ST; Delisle VC; Pépin M; Malcarne VL; Carrier ME; Kwakkenbos L; Peláez S; El-Baalbaki G; Thombs BD;
    J Scleroderma Relat Disord; 2018 Feb; 3(1):106-111. PubMed ID: 35382120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Support Groups in Scleroderma.
    Rice DB; Thombs BD
    Curr Rheumatol Rep; 2019 Feb; 21(4):9. PubMed ID: 30790067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional study of Australian medical student attitudes towards older people confirms a four-factor structure and psychometric properties of the Australian Ageing Semantic Differential.
    Wilson M; Tran Y; Wilson I; Kurrle SE
    BMJ Open; 2020 Aug; 10(8):e036108. PubMed ID: 32801196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D simulation of aneurysm clipping: Data analysis.
    Mery F; Méndez-Orellana C; Torres J; Aranda F; Caro I; Pesenti J; Rojas R; Villanueva P; Germano I
    Data Brief; 2021 Aug; 37():107258. PubMed ID: 34277905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study.
    Riehm KE; Kwakkenbos L; Carrier ME; Bartlett SJ; Malcarne VL; Mouthon L; Nielson WR; Poiraudeau S; Nielsen K; Baron M; Frech T; Hudson M; Pope J; Sauve M; Suarez-Almazor ME; Wigley FM; Thombs BD;
    Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1195-200. PubMed ID: 26619042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of training and support programs for leaders of illness-based support groups: commentary and updated evidence.
    Turner KA; Rice DB; Carboni-Jiménez A; Boruff J; Thombs BD
    Syst Rev; 2019 Mar; 8(1):67. PubMed ID: 30836989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.
    Mills SD; Kwakkenbos L; Carrier ME; Gholizadeh S; Fox RS; Jewett LR; Gottesman K; Roesch SC; Thombs BD; Malcarne VL;
    Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1557-1562. PubMed ID: 29342510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.